Patents Assigned to Cambridge Univeristy Hospitals NHS Foundation Trust
  • Patent number: 9481716
    Abstract: The present invention relates to oral immunotherapy for the desensitization of patients who are hypersensitive to peanut allergen. The immunotherapy comprises increasing the oral dose daily dose of peanut protein administered to the patient at intervals of at least 2 weeks in a series of increments from an initial dose to a maximum dose, the series of dose increments including 2 mg, 5 mg, 12.5 mg, 25 mg, 50 mg, 100 mg, 200 mg, 400 mg and 800 mg; administering a daily oral dose of the maximum dose of peanut protein for at least 2 years and then administering a weekly oral dose of the maximum dose of peanut protein for at least 2 years.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: November 1, 2016
    Assignee: Cambridge Univeristy Hospitals NHS Foundation Trust
    Inventors: Andrew Clark, Pamela Ewan